Clinical trial · Interventional
Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.
Evaluation of Acupression's Bracelets Associated to an Educational Step Versus Education Only in Nausea and Vomiting's Mastering Induced by FEC100 Chemotherapy's Sort.
NCT00268125CI-TRIAL-00002137completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to demonstrate a betterment of the digestive symptomatology by the anti-emetic acupression's bracelets's use associated with hygiene and dietetic advices.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupression's bracelet | Device | — | UNRESOLVED |
| Hygiene and dietetic advices | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Reduction of 15% of stage III/IV nausea and vomiting's incidence.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Woman * Age \> 18 years * Well-informed written consent, signed by the patient before the beginning of the study * Breast cancer's diagnosis (operated or not) * Forecast of a treatment by FEC100 chemotherapy's sort (D1=D21) during at least 3 cycles. * Patient affiliated at a welfare or beneficiary from it * Investigator estimates that the patient is able to conform with protocol's conditions and to respect them Exclusion Criteria: * Operated arm's lymphedema * Wrist's morphology which cannot permit the bracelet's wearing (20 cm) * D1=D15 FEC100's treatment * Psychic incapability to sign a well-informed consent * Refusal to give a written consent * Patient under tutelage or guardianship * Pregnant or breast-feeding woman * Any clinical trial's participation which would impose nausea and vomiting's treatment modalities
References
Publications (0)
Data not yet available
No reference posted for this study.